Electro-catalysis by immobilised human flavin-containing monooxygenase isoform 3 (hFMO3)

被引:21
|
作者
Castrignano, Silvia [1 ]
Sadeghi, Sheila J. [1 ]
Gilardi, Gianfranco [1 ]
机构
[1] Univ Turin, Dept Human & Anim Biol, I-10123 Turin, Italy
关键词
Flavin-containing monooxygenase; Glassy carbon electrode; Glutaraldehyde gel; Bovine serum albumin; GLASSY-CARBON ELECTRODE; ADENINE-DINUCLEOTIDE; N-OXYGENATION; FMO3; POLYMORPHISMS; SENSOR; CYTOCHROME-P450; SPECIFICITY; ENZYME;
D O I
10.1007/s00216-010-4014-z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human flavin-containing monooxygenases are the second most important class of drug-metabolizing enzymes after cytochromes P450. Here we report a simple but functional and stable enzyme-electrode system based on a glassy carbon (GC) electrode with human flavin-containing monooxygenase isoform 3 (hFMO3) entrapped in a gel cross-linked with bovine serum albumin (BSA) by glutaraldehyde. The enzymatic electrochemical responsiveness is characterised by using well-known substrates: trimethylamine (TMA), ammonia (NH3), triethylamine (TEA), and benzydamine (BZD). The apparent Michaelis-Menten constant (K'(M)) and apparent maximum current (I'(max)) are calculated by fitting the current signal to the Michaelis-Menten equation for each substrate. The enzyme-electrode has good characteristics: the calculated sensitivity was 40.9 +/- 0.5 mA mol(-1) Lcm(-2) for TMA, 43.3 +/- 0.1 mA mol(-1) Lcm(-2) for NH3, 45.2 +/- 2.2 mA mol(-1) Lcm(-2) for TEA, and 39.3 +/- 0.6 mA mol(-1) Lcm(-2) for BZD. The stability was constant for 3 days and the inter-electrode reproducibility was 12.5%. This is a novel electrochemical tool that can be used to investigate new potential drugs against the catalytic activity of hFMO3.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 50 条
  • [41] Functional activity of mouse flavin-containing monooxygenase forms 1, 3, and 5
    Zhang, Jun
    Cerny, Matt A.
    Cashman, John R.
    DRUG METABOLISM REVIEWS, 2006, 38 : 203 - 204
  • [42] Benzydamine metabolism in vivo is impaired in patients with deficiency of flavin-containing monooxygenase 3
    Mayatepek, E
    Flock, B
    Zschocke, J
    PHARMACOGENETICS, 2004, 14 (11): : 775 - 777
  • [43] Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
    Ji Miao
    Alisha V. Ling
    Praveen V. Manthena
    Mary E. Gearing
    Mark J. Graham
    Rosanne M. Crooke
    Kevin J. Croce
    Ryan M. Esquejo
    Clary B. Clish
    David Vicent
    Sudha B. Biddinger
    Nature Communications, 6
  • [44] Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
    Miao, Ji
    Ling, Alisha V.
    Manthena, Praveen V.
    Gearing, Mary E.
    Graham, Mark J.
    Crooke, Rosanne M.
    Croce, Kevin J.
    Esquejo, Ryan M.
    Clish, Clary B.
    Vicent, David
    Biddinger, Sudha B.
    NATURE COMMUNICATIONS, 2015, 6
  • [45] OXYGENATION ACTIVITIES OF THE FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3) VARIANTS FOUND IN JAPANESE
    Nagashima, Satomi
    Shimizu, Makiko
    Yano, Hiroshi
    Murayama, Norie
    Yamazaki, Hiroshi
    DRUG METABOLISM REVIEWS, 2007, 39 : 260 - 260
  • [46] Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3)
    Allerston, Charles K.
    Shimizu, Makiko
    Fujieda, Masaki
    Shephard, Elizabeth A.
    Yamazaki, Hiroshi
    Phillips, Ian R.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (10): : 827 - 839
  • [47] Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria
    Zhang, J
    Tran, Q
    Lattard, V
    Cashman, JR
    PHARMACOGENETICS, 2003, 13 (08): : 495 - 500
  • [48] Polymorphisms of Flavin-Containing Monooxygenase 3 (FMO3) Gene in Healthy Turkish Population
    Topal, Pinar
    Ozhan, Gul
    DRUG METABOLISM REVIEWS, 2010, 42 : 231 - 231
  • [49] Flavin-containing monooxygenase isoform 2: Developmental expression in fetal and neonatal rabbit lung
    Larsen-Su, S
    Krueger, SK
    Yueh, MF
    Lee, MY
    Shehin, SE
    Hines, RN
    Williams, DE
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 1999, 13 (3-4) : 187 - 193
  • [50] Antibodies to a synthetic peptide that react with flavin-containing monooxygenase (HLFMO3) in human hepatic microsomes
    Myers, CR
    Porgilsson, B
    Myers, JM
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1997, 37 (02) : 61 - 66